Mukhtar, S. and Haris, M. 2023. Teplizumab: an FDA- approved drug, marks milestone in treatment of type 1 diabetes . International Journal of Scientific Reports. 10, 1 (Dec. 2023), 29–30. DOI:https://doi.org/10.18203/issn.2454-2156.IntJSciRep20233870.